The TechBio Opportunity in Belgium
BVI.EU is a leading European developer dedicated to pioneering light industrial real estate and advancing sustainability practices within the industry. In 2021, we launched a Life Sciences division aimed at achieving excellence in biotech real estate with tailored solutions. Our focus is on developing cutting-edge science parks dedicated to science and technology within highly dynamic ecosystems featuring world-class academic and industrial players.
We are thrilled to introduce our flagship project, Quantum Biospace, a 70,000 sqm science park situated on an 18-hectare plot in the Brussels Greater Area, at the heart of Belgium. The project is adjacent to GSK’s vaccine manufacturing site and UCLouvain, and is within a 30-minute drive from UCB, KULeuven, IMEC, and many other prominent institutions.
The project is now ready for precommercialization and includes 25,500 sqm of R&D facilities, 32,500 sqm of manufacturing space, and 8,000 sqm of offices, all within a premium environment featuring amenities, landscaped gardens, bike lanes, walkways, and inviting esplanades designed for people to gather and relax. BVI.EU is offering optionality around levels of finish from shell & core to fully fitted facilities and built-to-suit.
If you are interested in exploring how expanding to Belgium can enhance your European footprint and accelerate your growth, BVI.EU is your single point of contact for evaluating potential locations. We offer an unparalleled soft-landing package to support your exploratory and decision-making process. Our dedicated team specializes in responding to your information and proposal requests, providing comprehensive support to deliver tailored real estate solutions. Please download Quantum Biospace’s soft-landing teaser.
Florence Bosco, Head of Biotech Business Development and Geoffroy Dumonceau, Chief Development Officer, are at your complete disposal and would be delighted to schedule an informative session at your convenience. Please contact them via our website.
